Mainstay Capital Management LLC ADV boosted its holdings in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 103.4% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 30,508 shares of the company's stock after buying an additional 15,509 shares during the quarter. Mainstay Capital Management LLC ADV's holdings in Procter & Gamble were worth $4,860,000 as of its most recent SEC filing.
Several other institutional investors also recently bought and sold shares of PG. Kingstone Capital Partners Texas LLC increased its holdings in Procter & Gamble by 655,209.0% during the second quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company's stock valued at $11,832,680,000 after buying an additional 76,017,350 shares during the period. Nuveen LLC purchased a new position in Procter & Gamble during the first quarter valued at approximately $1,954,941,000. Price T Rowe Associates Inc. MD grew its holdings in Procter & Gamble by 13.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company's stock worth $3,660,737,000 after purchasing an additional 2,466,308 shares during the last quarter. Invesco Ltd. grew its holdings in Procter & Gamble by 19.8% in the first quarter. Invesco Ltd. now owns 13,493,604 shares of the company's stock worth $2,299,580,000 after purchasing an additional 2,228,151 shares during the last quarter. Finally, Valeo Financial Advisors LLC grew its holdings in Procter & Gamble by 1,875.5% in the second quarter. Valeo Financial Advisors LLC now owns 1,763,404 shares of the company's stock worth $280,946,000 after purchasing an additional 1,674,139 shares during the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Several equities analysts have issued reports on PG shares. UBS Group cut their price target on shares of Procter & Gamble from $180.00 to $176.00 and set a "buy" rating on the stock in a report on Wednesday. Weiss Ratings reaffirmed a "hold (c+)" rating on shares of Procter & Gamble in a report on Wednesday. Barclays cut their price target on shares of Procter & Gamble from $164.00 to $153.00 and set an "equal weight" rating on the stock in a report on Wednesday, October 1st. JPMorgan Chase & Co. reissued a "neutral" rating and set a $170.00 price objective (down from $178.00) on shares of Procter & Gamble in a report on Friday, July 25th. Finally, Bank of America dropped their price objective on shares of Procter & Gamble from $180.00 to $174.00 and set a "buy" rating on the stock in a report on Wednesday. Eleven equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $172.58.
Get Our Latest Report on Procter & Gamble
Insider Activity at Procter & Gamble
In related news, CEO Gary A. Coombe sold 10,194 shares of the business's stock in a transaction on Thursday, August 21st. The shares were sold at an average price of $158.16, for a total transaction of $1,612,283.04. Following the completion of the transaction, the chief executive officer directly owned 34,978 shares in the company, valued at $5,532,120.48. The trade was a 22.57% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Marc S. Pritchard sold 9,849 shares of the company's stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $1,548,952.23. Following the completion of the transaction, the insider owned 182,422 shares of the company's stock, valued at approximately $28,689,507.94. This trade represents a 5.12% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 149,763 shares of company stock valued at $23,421,279 over the last ninety days. Corporate insiders own 0.20% of the company's stock.
Procter & Gamble Trading Down 0.1%
NYSE PG opened at $150.53 on Friday. The company has a market capitalization of $352.31 billion, a PE ratio of 23.12, a P/E/G ratio of 4.00 and a beta of 0.36. The company has a fifty day moving average of $155.26 and a 200 day moving average of $159.62. Procter & Gamble Company has a 1 year low of $149.58 and a 1 year high of $180.43. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49.
Procter & Gamble (NYSE:PG - Get Free Report) last posted its earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.42 by $0.06. The company had revenue of $20.89 billion during the quarter, compared to the consensus estimate of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The firm's quarterly revenue was up 1.7% on a year-over-year basis. During the same period in the previous year, the firm posted $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Research analysts forecast that Procter & Gamble Company will post 6.91 earnings per share for the current year.
About Procter & Gamble
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report